The Story Of Our Firm | En Español
 Home    Lawyers   Litigation   Why Choose Us?   Results   Search

Drugs ReNu MoistureLoc Research Center

MultiPlus Recall, 3/07

in this section: FDA ReNu Recall | W & L Press Release | FDA: Failure to Report, 11.06 | B&L Responds: ReNu FDA Letter 11.06 | FDA Warning | Litigation Proliferates, 10.07 | FDA Supports Withdrawal | FDA Public Health Notice | B&L Sales Fall | Bausch & Lomb Press Release | MultiPlus Recall, 3/07 | ReNu lawsuit


Bookmark This Page Print This Page Email This Page

FDA Alert: Bausch & Lomb Recall of 12 Lots of ReNu MultiPlus Solutions

FOR IMMEDIATE RELEASE -- Rochester, New York -- March 6, 2007 -- Bausch & Lomb (NYSE/BOL) has initiated a limited voluntary recall from distribution centers and retail shelves in the United States and specific other countries of 12 lots of ReNu MultiPlus lens care solution made at its plant in Greenville, SC because they contain an elevated level of trace iron. This may result in discoloration of the solution in some bottles, and the shelf life of the product may be shortened to less than its two-year expiration date, due to a potential loss of effectiveness over time. The Company has received no reports of serious adverse events associated with these lots and believes virtually all of the affected product, manufactured about a year ago, has already been used by consumers. Bausch & Lomb has notified the U.S. Food and Drug Administration of this voluntary action.

About a million bottles of solution from nine of the 12 lots were originally distributed in the United States. Product from the 12 affected lots was also distributed in Canada, Latin America, Korea and Taiwan, where it is also being recalled.

The company initiated an investigation after receiving three customer reports of discolored solution. The root cause of the discoloration was determined to be an elevated level of trace iron in a single batch of raw material sourced from an outside supplier. Iron is an element present at trace levels – measured in parts per billion – in many compounds used in manufacturing food, drug, medical device and cosmetic products for human use. The elevated level of trace iron could combine with other compounds in the solution to cause discoloration which signals that the solution may be losing effectiveness over time.

"We have always maintained that the health and safety of consumers is our top priority," said Angela J. Panzarella, vice president and head of Bausch & Lomb's global vision care business. "With detailed and specific information about the distribution of the affected product, and good information about consumer use patterns, we are highly confident that virtually all of the affected product was used before it began to lose effectiveness. We're now in the process of confirming with distributors and retailers that there is no product still available for sale anywhere."

"We are confident we have identified the source of the problem and we are taking appropriate measures designed to avoid a recurrence," Panzarella said.

Bausch & Lomb does not expect the costs associated with this limited recall will have a significant impact on its financial results.

If consumers notice that their lens care solution appears to be discolored, they should discard it, as it may be losing effectiveness. The recalled lots all carry the expiration date "2008 – 03" on the bottle. Consumers who have bottles from the lot numbers listed below should check the Company's web site at www.bausch.com/productrecall or call the consumer affairs line (1-866-259-8255) to arrange for a replacement.

LOT NUMBERS SUBJECT TO RECALL: GC6030 – GC6037 – GC6038 – GC6045 – GC6048 – GC6052 – GC6061 – GC6063 – GC6072 – GC6073 – GC6080 – GC6085

Click To Talk To Us Online

Please complete the following questionnaire:

Name
Email
Phone Number
How long have you worn contact lenses?
How long have you been using ReNu MultiPlus contact lens solution?
Have you developed: fungal eye infection
any loss of vision
Were you using ReNu MultiPlus in the month prior to your eye infection?Yes
No
Have you sought treatment from a physician for your symptoms?Yes
No
Have you had a corneal transplant?Yes
No
If yes to any of the above, please describe:
Additional Comments/Questions


see also:

FDA Supports Withdrawal FDA Supports Withdrawal of Bausch & Lomb ReNu MoistureLoc
The FDA Supports Withdrawal of ReNu MoistureLoc Contact Lens Solution

FDA Warning FDA warns against Bausch & Lomb's ReNu with MoistureLoc lens solution
Legal help for people with eye infections from Bausch & Lomb's ReNu

News & Warnings ReNu Lawsuit - Bausch & Lomb’s Contact Lens Solution News & Warnings
Keep up to date with ReNu Brand contact lens solution News & Warnings


Name Phone Email
Do you have a legal question? Ask us!   strictly confidential
Your Question

Click here
for a free case review



$53 million verdict — brake mechanic suffering from mesothelioma

$13.5 million verdict — one of the very first Vioxx trial cases

$15 million settlement — man wound up a paraplegic due to negligent hospital care

$37 million verdict — 2 asbestos lung cancer plaintiffs

$47 million verdict — boilermaker who died from mesothelioma

$75 million verdict — historic consolidated trial involving men who had worked at the Brooklyn Navy Yard in the 1940s and 1950s

$12.7 million verdict — iron worker who was injured due to unsafe working conditions

$64.65 million award — 4 asbestos plaintiffs

$17.5 million — consolidated trial of 5 mesothelioma victims

$25 million jury verdict — brake reliner

$5.8 million settlement — failure to perform timely C-Section

$30 million verdict — 7 former power-plant workers suffering from asbestos-related illnesses

$6 million settlement — pediatric malpractice case

$14 million consolidated verdict — 5 asbestos-related cancer suits: shipyards/powerhouses/construction

$8 million settlement — obstetrical malpractice resulted in neurological deficits

$3.5 million — 2 asbestos exposure cases

$600,000 settlement — motor vehicle negligence resulting in serious injury

$44 million verdict — 5 asbestos cases, including $11.6 million awarded to widow of sheet metal worker who died of mesothelioma

$1.6 million settlement — suicide after premature hospital discharge

$2.6 million settlement — ill-fitting prosthesis caused decubitus ulcers

$1.5 million settlement — construction worker fell off elevated train tracks

$750,000 settlement — defective construction equipment resulted in serious injury to worker



Ask a Free Question:
Were you injured?

check for your response [login]
For legal help anywhere in the U.S.
A nationally-recognized personal injury law firm, Weitz & Luxenberg is committed to helping clients win cases, get the compensation to which they’re entitled and continue with their lives. In just over 20 years, we’ve collected more than $1.3 billion for plaintiffs.